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Nitric oxide (NO) has a much stronger affinity for hemoglobin than carbon monoxide (CO);
therefore, the DLNO (diffusing capacity for NO) is less influenced by changes in capillary
blood volume than the DLCO (diffusing capacity for CO), and represents the true membrane
diffusing capacity.
We measured the combined single breath DLNO/DLCO in 124 healthy subjects, and
generated reference equations for the DLNO and KNO. In a subset of 21 subjects the
measurements were performed on different inspiratory levels.
The reference equation for DLNO in females is 53:47nHðheightÞ0:077nAðageÞ 
48:28ðRSD5:22Þ and for males 59:84nH  0:25nA 44:20ðRSD6:39). Reference equations
for KNO in females is 2:03nH  0:025nAþ 11:52ðRSD0:48Þ and for males 0:15nH
0:045nAþ 9:47ðRSD0:65Þ. The KCO (DLCO/VA) increases when VA (alveolar volume)
decreases, probably due to an increase of blood volume per unit lung volume.
The DLNO was much stronger related to the VA, the KNO was almost independent of VA.
Because of the relative independence of the KNO on VA, the KNO appears to be a much
better index for the diffusion capacity per unit lung volume (transfer coefficient) than
the KCO.
& 2006 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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van der Lee).Introduction
The carbon monoxide (CO) diffusing capacity of the lung
(DLCO), also known as the transfer factor, is a commonly used
measure for lung gas uptake. The single breath approach is
mostly used because it is a fast method with good
reproducibility. The CO lung uptake is influenced by two
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I. van der Lee et al.1580factors: (1) the diffusion-limited passage of CO through the
alveolocapillary membrane and (2) the passage of the CO
through the plasma, the intra-erythrocytic compartment
and the chemical binding to hemoglobin. The latter process
leads to a decreased DLCO in case of anemia and/or reduced
capillary blood volume. Roughton and Forster constructed
the well-known equation: 1=DLCO ¼ 1=DmCO þ 1=ynVcap,
where DmCO is the membrane diffusing capacity for CO,
yCO the CO uptake by erythrocytes and Vcap the pulmonary
capillary blood volume. For the correct interpretation of the
DLCO, clinicians need to be aware that the alveolocapillary
membrane resistance approximately accounts for half of the
total resistance.1 Another important issue is lung size: larger
lungs show a stronger CO uptake and therefore the DLCO is
dependent on alveolar volume (VA). In search for an index
independent of lung size, clinicians often use the KCO, or
transfer coefficient, defined as the DLCO divided by VA.
Unfortunately, the KCO increases when VA is (voluntary)
decreased,2,3 probably due to a relative increase in blood
volume per unit lung volume.2 This phenomenon makes the
KCO hard to interpret
4 in subjects with a small total lung
volume, as is frequently seen in interstitial lung disease.
Many authors proposed methods for correction of the KCO
when VA is lower than its normal high value,
3,5–7 but these
methods have never been adopted on a wide scale.
Due to the high affinity of nitric oxide (NO) to hemoglobin,
the nitric oxide diffusing capacity (DLNO) reflects the proper-
ties of the alveolocapillary membrane much better than the
DLCO.
8 The strong binding of NO to hemoglobin leads to a very
high value for yNO, thus the last term in the Roughton and
Forster equation equals zero (1=DLNO ¼ 1=DmNO). Therefore
DLNO can be defined as the true alveolocapillary membrane
diffusing capacity.9 The DLNO only has been investigated by a
small group of researchers, and is still not implemented in
clinical routine. As far as we know, reference values for the
single breath DLNO test are not available yet, because in
previous studies8,10 too few subjects were tested to generate
useful reference equations.
Because the DLNO is not influenced by pulmonary capillary
blood volume, we hypothesized that the KNO will not react
to the relative increase in lung blood volume at decreasing
VA. If the membrane itself will not change (i.e. will not
become thicker) during decreasing VA, the KNO will be
independent of VA, and can be considered as the true
membrane diffusing coefficient.
This study was performed to generate clinical useful
reference values for the single breath DLNO, and to investigate
the dependence of the DLNO and the KNO on the alveolar volume.Methods
DLNO measurement
A standard DLCO apparatus (MasterLab Pro, Erich Jaeger
GmbH, Wurzburg, Germany) was changed drastically. An
electronic switchboard was added which followed the
processing of the apparatus, thereby controlling the addi-
tion of a small amount of NO in N2 (750 ppm, Hoekloos
Medical, the Netherlands) to the standard test gas contain-
ing CO 0.25%, helium 9% with balance air. The NO was added
shortly before the measurement, the concentration in theinhalation mixture was 7–9 ppm. In the exhaled air a small
amount of the sample was lead via a side arm to an NO-
chemoluminescence analyzer with rapid reaction time (CLD
77 AM, Eco Physics, Zurich, Switzerland). The exhaled NO
levels were always higher than 100 ppb; therefore, the
disregard of the NO backpressure was justified. Earlier
investigation showed an alveolar NO level of approximately
2 ppb in healthy subjects.11 At the very fast exhalation
flows, we used NO production by the conducting airways
which can be neglected.12 The alveolar NO levels of healthy
subjects and of asthmatic subjects are the same, because
the higher exhaled NO levels measured in asthmatic subjects
are due to increased NO production by the conducting
airways. The analyzer was calibrated with 5 ppm NO in
nitrogen and NO-free air. The output from the NO-analyzer
was transferred to a personal computer and later offline
combined with the data from the DLCO apparatus. The single
breath procedure was performed according to ATS recom-
mendations13 with an effective breath-holding period of
10 s, discard volume 750ml, sample volume 750ml. The
DLNO and DLCO measurements were performed simulta-
neously. A minimum of two measurements were performed,
in which a change of 10% or less of the DLCO and the VA was
acceptable. The DLNO is calculated according to the
equation: DLNO ¼ VA/tln(FiNO/FaNO)1/Pb  PH2O (VA is
alveolar volume BTPS corrected, t is effective breath-
holding time, FiNO is inspiratory alveolar NO concentration,
FaNO is expired alveolar NO concentration, Pb is atmospheric
pressure and PH2O is the vapor pressure of water at 37 1C,
which is 6.3 kPa).8
Reference equations study
The combined single breath DLNO and DLCO was measured in
healthy volunteers who were recruited from local hospital
personnel. Anemia was an exclusion criterion. The DLCO was
not corrected for hemoglobin concentration, because in
subjects with normal hemoglobin levels the correction only
leads to very small changes.2 In all subjects whole-body
plethysmography was performed (6200 Autobox DL, Sensor-
Medics Cooperation, Yorba Linda, CA, USA) with the
determination of static and dynamic lung volumes. Inclusion
criteria consisted of never smokers without pulmonary
complaints and without medication. Exclusion criteria
consisted of serious chronic illnesses, a history of asthma
or other pulmonary diseases and diabetes mellitus. This
study had been approved by our local ethics committee and
informed consent was obtained from each participant.
VA dependency study
A subset of the subjects included in the reference equation
study performed combined DLNO/DLCO measurements when
inspiring to 50%, 70% and 100% of TLC. The DLCO, DLNO, KCO,
KNO and VA were expressed as fraction of the value at TLC.
3
Statistics
Linear regression analysis (SPSS for Windows version 11.0,
SPSS Inc, Chicago, USA) was used to calculate the relation
between the DLCO, the DLNO, the KCO and the KNO versus VA.
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Table 2 Summary of diffusion parameters.
Females (59) Males (65)
VA (L) 5.570.9
* 7.471.0
DLCO (mmol/min/kPa) 9.271.6
* 12.072.2
DLCO %pred (12) 100.1714.9
ns 104.1715.1
DLNO (mmol/min/kPa) 39.176.3
* 54.378.7
DLNO/DLCO 4.370.4
* 4.670.5
KCO (mmol/min/kPa/L) 1.770.2
ns 1.670.3
KCO %pred (12) 98.2711.7
* 105.8714.1
KNO (mmol/min/kPa/L) 7.170.6
ns 7.470.9
Depicted are means7standard deviation (SD); *po0.01; ns
not significant.
Table 3 Regression equations for the diffusion para-
meters in female and male subjects.
Sex Regression equation RSD
DLNO, females 53:47nH  0:077nA 48:28 5.22
DLNO, males 59:84nH  0:25nA 44:20 6.39
DLCO, females 10:51nH  0:030nA 7:43 1.37
DLCO, males 12:02nH  0:074nA 6:88 1.74
KCO, females 0:88nH  0:0083nAþ 3:48 0.20
KCO, males 0:14nH  0:012nAþ 2:37 0.22
KNO, females 2:03nH  0:025nAþ 11:52 0.48
KNO, males 0:15nH  0:045nAþ 9:47 0.65
DLCO, females, ERS 8.18H0.049A2.74 1.17
DLCO, males, ERS 11.11H–0.066A6.03 1.41
For comparison the ERS (12) reference equations are
displayed in the two lower rows (in italics). H is height in
m, A is age in years, RSD is residual standard deviation.
NO diffusing capacity 1581For generation of the reference equations, a correlation
matrix was produced in search of factors dependent of the
DLNO, KNO and VA. Linear regression analysis was used to
calculate the regression equations. Data are presented as
means7standard deviation (SD), significance was defined as
po0.01.
Results
Reference equations study
A total of 124 healthy subjects were enrolled, 59 females
and 65 males. All had normal flow-volume loops, and normal
values for DLCO
14 and TLC.15 The characteristics of the study
population are shown in Table 1: we observed no statistically
significant differences in the pulmonary function parameters
between the male and female subjects, when expressed as
percent predicted values. The mean values for the diffusion
parameters are displayed in Table 2. The mean DLCO was
100.1% of the predicted value in women and 104.1% of the
predicted value in men. The KCO as percentage of predicted
differed slightly but significantly between males and
females. We constructed reference equations for all diffu-
sion parameters (Table 3). The reference equations we
constructed for the DLCO were comparable with the ERS
reference equations,14 for men as well as women (Table 3).
The ERS reference equations for the KCO are defined as the
DLCO reference divided by the TLC reference. The question
remains whether this is a valid method to calculate
reference equations16; nonetheless, we used the ERS
equations to evaluate the KCO values we found, although
our equations are hard to compare with the ERS equations.
We found that the DLNO is about 4.5 times higher than the
DLCO, in concordance with the findings of others.
8 In this
study the DLNO strongly depends on height, for female as
well as male subjects.9
VA dependency study
In the VA dependency study 21 subjects were included, 15
female and 6 male, mean age 39 years. All subjects had
normal DLCO and VA.
14 We observed a decrease of the DLNO
and to a lesser extent the DLCO with a lowering of VA. ATable 1 Characteristics of the study population.
Females (59) Males (65)
Age (years) 37.9711.8ns 40.1712.6
Height (m) 1.6970.07* 1.8270.07
Weight (kg) 77.0710.1* 80.4710.2
TLC (L) 5.970.9* 7.971.0
FEV1/FVC 0.8170.06
ns 0.8170.05
FEV1%pred 107.3714.0
ns 112.7715.7
FVC %pred 114.5716.4ns 113.1714.4
TLC %pred 110.0712.4ns 105.7712.4
VA (L) 5.570.9
* 7.471.0
VA/TLC 0.9470.06
ns 0.9370.06
Depicted are means7standard deviation (SD); *po0.01; nsnot
significant.strong negative relation was seen between the KCO and the
VA (Fig. 1): the KCO increases when VA decreases. The KNO
only slightly increases when VA decreases (Fig. 2). Because
of the different response of the DLNO and DLCO on inspiratory
level, the DLNO/DLCO ratio decreases when the VA diminishes
(Fig. 3). We constructed equations for all diffusion para-
meters as percentage of the value at maximal TLC (Table 4).Discussion
The use of the DLNO for assessing the function of the
alveolocapillary membrane is supported by several studies
that pointed out that the DLNO constitutes the true alveolar
membrane diffusing capacity.9,17,18 The DLCO is stronger
influenced by the binding of CO to hemoglobin,1,19 thus it is
a factor that is considerably influenced by the pulmonary
microcirculation. It is therefore remarkable that many
clinicians consider the DLCO as a function of the alveoloca-
pillary membrane. The DLNO has more right to claim that
title, because the DLNO is not or less affected by capillary
blood volume, and therefore it is more informative of the
function of the alveolocapillary membrane than the DLCO.
We generated reference equations for the DLNO and KNO
that can be used in clinical practice. We have tested
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Figure 1 DLCO (open circles) as a fraction of the value at TLC, KCO (closed diamonds) as a fraction of the value at TLC, versus VA
depicted as the fraction of the value at TLC.
Figure 2 DLNO (open circles) as a fraction of the value at TLC, KNO (closed diamonds) as a fraction of the value at TLC, versus VA
depicted as the fraction of the value at TLC.
I. van der Lee et al.1582a relative young population, mainly due to the fact that we
accrued subjects working in the hospital, which is over-
populated with young personnel. In our opinion the relative
young age of the study sample does not lead to major bias,
because the reference equations we calculated for the DLCO
matches with the standard ERS reference equations.7
In the second part of this study, we observed an increase in
KCO when VA decreases in 21 healthy subjects, which is in
concordance with the results of Johnson.3 Furthermore we
studied the relation between the DLNO and the VA, which
proved to be very strong, more or less to the same extent as
Borland et al.8 The slope between DLCO and VA is lower than
the slope between DLNO and VA because the relative decrease
in blood volume when VA increases leads to the lowering of the
DLCO. The fact that the DLNO strongly depends on the height
(and thus on VA) raises the question what the additional valueis of the DLNO next to the DLCO and VA. When performing
combined single breath DLNO and DLCO measurements, both
values can be interpreted as percentage of predicted values.
When for example the DLCO is decreased and the DLNO is
normal in a subject without restriction and without anemia,
this indicates that the pulmonary capillary blood volume is
diminished. When both DLCO and DLNO values are decreased, a
malfunction of the alveolocapillary membrane is likely.
Instead of the percentage predicted values the DLNO/DLCO
ratio can be used: in subjects without restriction a lowering of
the ratio indicates an (relative) increase in capillary blood
volume. Seen in this way, the DLNO adds information to the
DLCO and VA measurements.
A more difficult question is what the clinical use of the
KNO could be. In concordance with the KCO, which is the rate
constant for CO uptake from alveolar gas,19 the KNO is a time
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Figure 3 DLNO/DLCO ratio versus VA depicted as the fraction of the value at TLC.
Table 4 Equations for the relation between diffusion parameters and alveolar volume (VA).
Parameter Equation
DLCO (mmol/min/kPa) DLCO=DLCO;TLC ¼ 0:42þ 0:58nVA=VA;TLC
DLNO (mmol/min/kPa) DLNO=DLNO;TLC ¼ 0:13þ 0:88nVA=VA;TLC
KCO (mmol/min/kPa/L) KCO=KCO;TLC ¼ 1:72 0:73nVA=VA;TLC
KNO (mmol/min/kPa/L) KNO=KNO;TLC ¼ 1:20 0:21nVA=VA;TLC
DLNO/DLCO DLNO=DLCO ¼ 2:50þ 2:06nVA=VA;TLC
NO diffusing capacity 1583function of removal of NO from alveolar gas. The KNO is four
and a half times larger than the KCO because of the fact that
the covalescence of NO to hemoglobin is much stronger than
for CO. Therefore, NO uptake is not limited by the amount
of hemoglobin present in the direct proximity of the alveolar
gas. The KCO increases when VA decreases due to the relative
increase of capillary blood volume per unit lung volume. The
KNO is not influenced by this phenomenon, and stays
unchanged. Therefore the KNO, as independent of capillary
filling, can be seen as a measure for the function of the
alveolocapillary membrane per unit lung volume. In fact,
the KNO is not completely independent of VA, as can be seen
in Figure 2. The KNO slightly increases with lowering of the
VA. This can be caused by two factors. At first it is possible
that the NO uptake is still limited by the binding to
hemoglobin; in other words 1/yNO cannot be neglected.
The second more likely explanation is that the matching of
ventilation and perfusion changes from TLC level to a lower
inspiratory level. At TLC level the upper lung zone areas are
recruited, with a relative underperfusion.20 In other words,
the upper lung zones are areas with greater dead space than
the lower lung zones. Although the DLNO and KNO are less
sensitive for capillary blood volume than the DLCO and KCO,
of course for uptake of NO the presence of capillaries (and
thus hemoglobin) is essential. In our opinion, this is a likely
explanation for the small increase in KNO with decreasing VA.The strong dependence of the KCO on VA has led to an
ongoing debate whether or not the KCO is useful in
restrictive lung diseases.6,21 When restriction is similar to
voluntary lowering of the inspiratory levels, the answers
would be yes. In our opinion, the truth is more complicated,
because in restrictive pulmonary disease vascular abnorm-
alities can play an important role.22 It will be difficult if not
impossible to determine whether the decreased KCO will be
due to decreased microvascularity or membrane dysfunc-
tion. In subjects with a restriction and a decreased KCO, the
KNO (as percentage predicted) can give additional informa-
tion: when normal, membrane dysfunction seems less
probable.
The classical way to measure the subdivisions (DmCO and
Vcap) of the DLCO with the high–low oxygen technique
23 is
time-consuming and not available in most pulmonary
function laboratories. The single breath combined DLNO/
DLCO takes no longer time than the DLCO measurement itself,
the equipment is not very complicated, only the necessity of
a chemoluminescence NO analyzer will need a financial
investment. Of course, further investigations will be needed
to explore the DLNO and KNO in subjects with restrictive
pulmonary diseases. The DLNO/DLCO ratio is a promising
measure because it is an easy-to-interpret value, which can
differentiate between various causes of a diminished
diffusion capacity.
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I. van der Lee et al.1584Conclusion
The DLNO resembles the true membrane diffusing capacity,
the KNO is a better representative of the function of the
alveolocapillary membrane than the DLCO because of the
relative insensitivity of the DLNO of capillary blood volume.
Therefore, the use of the DLNO and KNO next to the DLCO and
KCO can have great clinical advantages. Now clinical useful
reference equations for the single breath DLNO and KNO are
available. The question remains whether the observed
independence of the KNO on VA in healthy subjects can be
transferred to diseased subjects.
We hope that this article can lead to the commercial
development of single breath DLNO apparatus, which can
give the pulmonary physician a new tool in the pulmonary
function laboratory.
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